Source: Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: MEDICAMENTO, BIOEQUIVALÊNCIA
ABNT
SANTOS, Everton Miranda dos et al. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, v. 112, n. 12, p. 3131-3140, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2023.07.012. Acesso em: 17 out. 2024.APA
Santos, E. M. dos, Ferraz, H. G., Issa, M. G., & Duque, M. D. (2023). Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space. Journal of Pharmaceutical Sciences, 112( 12), 3131-3140. doi:10.1016/j.xphs.2023.07.012NLM
Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012Vancouver
Santos EM dos, Ferraz HG, Issa MG, Duque MD. Development of extended-release formulations containing cyclobenzaprine based on physiologically based biopharmaceutics modeling and bioequivalence safe space [Internet]. Journal of Pharmaceutical Sciences. 2023 ; 112( 12): 3131-3140.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.xphs.2023.07.012